company

HURDAL BIOVARME AS

2090 HURDAL

Return on Equity
11,47 %
Current Ratio
1,73
Debt-to-Equity Ratio
0,56
Key figures (NOK)2022
Revenue1 166 000
Net Income114 000
Total Assets1 707 000
Total Equity994 000
Income (NOK)2022
Revenue1 166 000
Expenditure990 000
Operating Profit177 000
Financial Income1 000
Financial Costs36 000
Financial Balance−35 000
Earnings Before Tax142 000
Tax28 000
Net Income114 000
Balance (NOK)2022
Total Fixed Assets1 428 000
Total Current Assets279 000
Total Assets1 707 000
Total Retained Equity244 000
Total Equity994 000
Total Long-Term Debt552 000
Total Current Debt161 000
Total Equity and Debt1 707 000
Cash flow (NOK)2022
Sales Income1 166 000
Other Income0
Revenue1 166 000
Cost of Goods Sold532 000
Salary Costs0
Depreciation111 000
Impairment0
Expenditure990 000
Operating Profit177 000
Financial Income1 000
Financial Costs36 000
Financial Balance−35 000
Dividends0
Net Income114 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate1 428 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets1 428 000
Total Fiancial Fixed Assets0
Total Fixed Assets1 428 000
Stock0
Total Investments0
Cash, Bank125 000
Total Current Assets279 000
Total Assets1 707 000
Total Equity994 000
Short-Term Group Debt0
Total Long-Term Debt552 000
Creditors128 000
Unpaid Taxes0
Dividends0
Other Current Debt5 000
Total Current Debt161 000
Total Equity and Debt1 707 000
Financial indicators2022
Return on Equity11,47 %
Debt-to-Equity Ratio0,56
Operating Profit Margin15,18 %
Current Ratio1,73
Quick Ratio1,73
Equity Ratio0,58
Gross Profit Margin54,37 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English